These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9839623)

  • 1. The impact of extracellular matrix on the chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.
    Baumgartner G; Gomar-Höss C; Sakr L; Ulsperger E; Wogritsch C
    Cancer Lett; 1998 Sep; 131(1):85-99. PubMed ID: 9839623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of extracellular matrix on chemoresistance of solid tumors--experimental and clinical results of hyaluronidase as additive to cytostatic chemotherapy.
    Baumgartner G
    Cancer Lett; 1998 Sep; 131(1):1-2. PubMed ID: 9839613
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyaluronidase in cytostatic therapy of ENT tumors].
    Baumgartner G; Neumann H
    Laryngol Rhinol Otol (Stuttg); 1987 Apr; 66(4):195-9. PubMed ID: 3600126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypericin uptake: a prognostic marker for survival in high-grade glioma.
    Ritz R; Müller M; Dietz K; Duffner F; Bornemann A; Roser F; Tatagiba M
    J Clin Neurosci; 2008 Jul; 15(7):778-83. PubMed ID: 18394904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Fukushima T; Yamamoto M; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 1998; 18(5D):3965-70. PubMed ID: 9854511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Established data and practical recommendations concerning pre- and postoperative chemotherapy of rectal cancer].
    Rougier P; Mitry E; Clavéro-Fabri MC; Penna C; Nordlinger B
    Ann Chir; 1999; 53(10):1011-8. PubMed ID: 10670150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding: Valero V, Buzdar AU, Hortobagyi GN. "Locally Advanced Breast Cancer," The Oncologist 1996;1:8-17.
    Oliver RT
    Oncologist; 1996; 1(4):278-279. PubMed ID: 10388003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current trials and new aspects in soft tissue sarcoma of adults.
    Issels RD; Schlemmer M
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of high-dose chemotherapy before radiation in children with newly diagnosed high-grade astrocytoma: final analysis of Children's Cancer Group Study 9933.
    MacDonald TJ; Arenson EB; Ater J; Sposto R; Bevan HE; Bruner J; Deutsch M; Kurczynski E; Luerssen T; McGuire-Cullen P; O'Brien R; Shah N; Steinbok P; Strain J; Thomson J; Holmes E; Vezina G; Yates A; Phillips P; Packer R
    Cancer; 2005 Dec; 104(12):2862-71. PubMed ID: 16315242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
    Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
    Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher glioblastoma tumour burden reduces efficacy of chemotherapeutic agents: in vitro evidence.
    Ng WH; Wan GQ; Too HP
    J Clin Neurosci; 2007 Mar; 14(3):261-6. PubMed ID: 17258135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma.
    Aref A; Narayan S; Tekyi-Mensah S; Varterasian M; Dan M; Eilender D; Karanes C; al-Katib A
    Radiat Oncol Investig; 1999; 7(3):186-91. PubMed ID: 10406061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase.
    Brekken C; Bruland ØS; de Lange Davies C
    Anticancer Res; 2000; 20(5B):3503-12. PubMed ID: 11131654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas.
    Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB
    J Clin Oncol; 2003 Jun; 21(12):2299-304. PubMed ID: 12805330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.